Researchers Propose Solutions to Improve GLP-1 RA Access
Physician's Weekly
JUNE 18, 2025
Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms.
52 
The MAHA Assessment’s Implications: Drugs (Part One)
FDA Law
JUNE 4, 2025
The Strategy must address appropriately restructuring the Federal Governments response to the childhood chronic disease crisis, including by ending Federal practices that exacerbate the health crisis or unsuccessfully attempt to address it, and by adding powerful new solutions that will end childhood chronic disease.
Let's personalize your content